{
  "url": "https://openlegislation.uk/eu-regulation-2019-2007/annex-I/chapter-30/division-1",
  "json_url": "https://openlegislation.uk/eu-regulation-2019-2007/annex-I/chapter-30/division-1.json",
  "legislation": "eur/2019/2007",
  "legislation_title": "Commission Implementing Regulation (EU) 2019/2007 of 18 November 2019 laying down rules for the application of Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the lists of animals, products of animal origin, germinal products, animal by-products and derived products and hay and straw subject to official controls at border control posts and amending Decision 2007/275/EC (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2019-2007",
  "path": "annex/I/chapter/30/division/1",
  "kind": "division",
  "number": null,
  "heading": "General remarks",
  "text": "Finished medicinal products, which are not covered by Regulation (EC) No 1069/2009 and (EU) No 142/2011, are excluded from the list. Intermediate products are included.\nIn heading 3001 (glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included) only animal derived products of subheadings 3001 20 and 3001 90 are relevant for official controls. Refer to the following specific requirements in Annex XIV to Regulation (EU) No 142/2011:\n1.. Row 2 of Table 2 in Section 1 of Chapter II for blood products for technical products excluding from equidae, and\n2.. Row 3 of Table 2 in Section 1 of Chapter II for blood and blood products from equidae, and\n3.. Row 14 of Table 2 in Section 1 of Chapter II for animal by-products for the manufacture of pet food other than raw pet food and of derived products for uses outside the feed chain.\nIn heading 3002 (human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products) only subheadings 3002 12 and 3002 90 are relevant for official controls. Human blood of 3002 90 10 and vaccines of subheadings 3002 20 and 3002 30 do not need to be subjected to official controls.\nCN code\nDescription\nQualification and explanation\n(1)\n(2)\n(3)\n3001 20 90\nExtracts of glands or other organs or of their secretions, other than of human origin\nAll; covers a product acting as a replacement for maternal colostrum and used in the feeding of calves.\nex 3001 90 91\nAnimal substances prepared for therapeutic or prophylactic uses: heparin and its salts\nAll animal products, which are destined for further processing, in accordance with Article 34(1) of Regulation (EC) No 1069/2009, for the manufacture of the derived products referred to in points (a) to (f) of Article 33 of that Regulation.\n3001 90 98\nOther animal substances than heparin and its salts prepared for therapeutic or prophylactic uses, not elsewhere specified or included\nAll.\nIn addition to the glands and other organs mentioned in the Harmonized System Explanatory Notes to heading 3001, (A), this subheading covers the hypophysis, the suprarenal capsules and the thyroid gland; except those specified in Article 33 of Regulation (EC) No 1069/2009.\nex 3002 12 00\nAntisera and other blood fractions\nAnimal derived products only.\nExcludes finished medicinal products for the final consumer.\nExcludes antibodies and DNA.\nUnder heading 3002, specific requirements are set out for animal by-products covered by Table 2 in Section 1 of Chapter II of Annex XIV to Regulation (EU) No 142/2011 and specified in the following Rows:\nRow 2: blood products other than from equidae;\nRow 3: blood and blood products from equidae.\n3002 90 30\nAnimal blood prepared for therapeutic, prophylactic or diagnostic uses\nAll\nex 3002 90 50\nCultures of micro organisms\nOnly pathogens and cultures of pathogens for animals.\nex 3002 90 90\nOther\nOnly pathogens and cultures of pathogens for animals.\nex 3006 92 00\nWaste pharmaceuticals\nAnimal derived products only.\nPharmaceutical waste, pharmaceutical products, which are unfit for their original intended purpose.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2019/2007/annex/I/chapter/30/division/1",
    "retrieved_at": "2026-11-01T14:43:00.700791+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}